Reactions Weekly

, Volume 1633, Issue 1, pp 661–661 | Cite as

Tafluprost/timolol

Increased blood pressure, chest discofort and asthenic conditions (physical deconditioning): 2 case reports
Case report
  • 49 Downloads

Reference

  1. Takagi Y, et al. Prospective Observational Post-marketing Study of Tafluprost 0.0015%/Timolol 0.5% Combination Ophthalmic Solution for Glaucoma and Ocular Hypertension: Short-Term Efficacy and Safety. Ophthalmology and Therapy 5: 191-206, No. 2, Dec 2016. Available from: URL: http://doi.org/10.1007/s40123-016-0057-3 - JapanCrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations